ClinicalTrials.Veeva

Menu

Prophylactic Antibiotic in Treatment of Fingertip Amputation

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Infection Rate After Fingertip Amputation

Treatments

Drug: Cephazolin

Study type

Interventional

Funder types

Other

Identifiers

NCT02077400
0115-09-EMC

Details and patient eligibility

About

Fingertip amputation is a common injury. Considerable controversy exists as to whether prophylactic antibiotics are necessary for this injury. The investigators goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment. The study hypothesis was that infection rates were similar in the two groups.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • fingertip amputation with bone exposed

Exclusion criteria

  • under the age of 18 years
  • if the patient had diabetes
  • oncological disorder
  • immune deficiency
  • bleeding disorder
  • used steroids regularly
  • presented with a grossly contaminated wound or other injury requiring antibiotic treatment
  • were currently taking antibiotics, or had a previous allergic reaction to cephalosporins.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

no antibiotic
No Intervention group
Cephazolin
Active Comparator group
Description:
cefazoline
Treatment:
Drug: Cephazolin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems